Facebook
Twitter
LinkedIn

Media Center

CLSI 2019 Professional Development Offerings: Sign up Now!
Facebook
Twitter
LinkedIn

Career development – particularly in a tight labor market – is an important recruitment strategy needed to attract the best talent. It is also an invaluable retention tool.

The California Life Sciences Institute (CLSI) is providing a full slate of professional development offerings – including seminars in the East San Francisco Bay and Southern California – for employees and other professionals who seek to build their skills in the life sciences industry, and for employers seeking to develop and retain their staff.

A quarterly calendar of these offerings can be found here, and a brief description of the courses follows:

BioBasics for non-scientists, a two-day course designed to give participants a working knowledge of the fundamental industry terms and applications, enabling more effective communication with colleagues. The course reviews the healthcare sectors and the scientific concepts required for understanding the biopharma industry. Building on this knowledge, the course delves into the cause of genetic and infectious disease, how disease is diagnosed, and the various therapeutic strategies used to mitigate disease. The latest innovations in immunotherapies, RNA technology, gene therapy, checkpoint inhibitors, CAR-T and more are explained.

Drug Development Immersion, an intensive two-day course in which participants learn the regulatory, commercial and scientific considerations required to successfully bring a drug to market. The course concentrates on the regulatory, commercial and scientific considerations required to successfully bring a drug to market. Discussion points will feature both small molecule and biologic products. Numerous personal accounts and war stories are used to illustrate the decision-making process companies use, giving participants a working knowledge of strategic development.

Drug Pricing and Reimbursement, a one-day course focusing on the complex relationship between drug manufactures, government policy, insurers, pharmacies, employers, and patients – particularly invaluable to those in government, finance, law, insurance, human resources. The course explains what a drug formulary is, how they differ from one another, and what considerations are accounted for when deciding which drugs to accept onto a formulary. It also explores the various constituents concerned with pharmacoepidemiology and how this information is used to inform drug policy, followed by pharmacoeconomics and the various methodologies of drug pricing and reimbursement. The course offers a detailed description of pricing and marketing strategies used by drug manufacturers, with consideration of a drug’s product lifecycle, direct-to consumer advertising, and discounts to various purchasers such as government and 340b entities.

From the Laboratory to Leadership helps participants assess who they are as leaders – their strengths, styles, and personal brand, and helps develop skills in the areas of communication, priority management, meeting management, goal setting and planning, delegation, performance management, and leading teams in a dynamic workplace. To drive high levels of engagement and impact, this program integrates learning pods, utilizes technology to measure progress and support a variety of learning styles, encourages participants to use their companies as learning labs, and helps clients set goals that deliver measurable results.

Leadership Edge for Women, a 6-part series (which can be taken as one-day workshops) designed to empower women leaders to get the EDGE, enabling them to excel within their companies, develop their authentic leadership style, gain support, skills, and tools, and elevate their success. Additional themes include: networking for success, developing an executive presence, leveraging emotional intelligence, and vision as a leadership tool. The curriculum is customized to the unique culture of each of the participants and is designed to achieve their specific goals.